Epidemiology of metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis and associated cardiometabolic factors in adults in China (2013-2023): A systematic review and meta-analysis

流行病学 医学 脂肪肝 脂肪性肝炎 代谢综合征 疾病 环境卫生 中国 系统回顾 肥胖 内科学 疾病负担 疾病负担 非酒精性脂肪性肝炎 肝病 脂肪变性 生物信息学 横断面研究 肝酶 营养流行病学 重症监护医学 梅德林 非酒精性脂肪肝 全球卫生 年轻人 公共卫生
作者
Shang-Yu Chai,Ru-Ya Zhang,Gail Fernandes,Yi-Man Zheng,Lai Wei
出处
期刊:World Journal of Gastroenterology [Baishideng Publishing Group]
卷期号:31 (46): 113608-113608 被引量:8
标识
DOI:10.3748/wjg.v31.i46.113608
摘要

BACKGROUND Although epidemiological data on non-alcoholic fatty liver disease in China are available, data on cardiometabolic risk factors have not been addressed under the metabolic dysfunction-associated steatotic liver disease (MASLD) consensus. AIM To synthesize the epidemiological characteristics of MASLD/metabolic dysfunction-associated steatohepatitis (MASH), especially their associated cardiometabolic risk factors in China. METHODS We searched EMBASE, MEDLINE, Central Cochrane, CNKI, and Wangfan for studies from January 1, 2013 to December 31, 2023. Studies involving individuals with MASLD/MASH in China that reported epidemiological outcomes were included. Meta-analysis was performed to assess the prevalence of MASLD/MASH. Exploratory outcomes included extrahepatic comorbidities and genetic variants related to MASLD. RESULTS In total, 561 studies involving 6632718 participants were included in this analysis. The prevalence of MASLD and MASH and the annual incidence of MASLD were 30.4% [95% confidence interval (CI): 29.4-31.3], 6.7% (95%CI: 2.2-13.4), and 37 cases per 1000 person-years (95%CI: 28-47), respectively. In addition, the prevalence rates of MASLD in individuals with dyslipidemia, obesity, and hypertension were 59.9% (95%CI: 52.6-67.0), 53.9% (95%CI: 47.9-59.9), and 44.3% (95%CI: 41.1-47.6), respectively. The prevalence of lean MASLD (body mass index < 24 kg/m2) was 12.0% (95%CI: 10.0-14.0), and 21.7% of the total MASLD population in China had lean MASLD. CONCLUSION This study provides a comprehensive overview of the epidemiology and disease burden of MASLD/MASH in China, providing additional evidence for optimizing MASLD/MASH management in China and a reference for the global understanding of MASLD/MASH epidemiology.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健的应助被拜见小山大王采纳,获得10
1秒前
1秒前
共享精神的应助被研友_赖冰凡采纳,获得10
1秒前
3秒前
4秒前
4秒前
Iris发布了新的文献求助10
5秒前
调皮彤发布了新的文献求助10
5秒前
初景的应助被Dawn采纳,获得20
6秒前
领导范儿的应助被Eli采纳,获得100
7秒前
8秒前
拜见小山大王完成签到,获得积分10
9秒前
所所的应助被Tuniverse_采纳,获得10
10秒前
酷炫冷卉完成签到 ,获得积分10
10秒前
汉堡包的应助被朴实的访曼采纳,获得10
11秒前
12秒前
152455发布了新的文献求助10
13秒前
14秒前
14秒前
寒冷的饼干完成签到 ,获得积分10
14秒前
15秒前
烟花的应助被DODO采纳,获得10
15秒前
学术文献互助的应助被辛未采纳,获得200
15秒前
Maestro_S的应助被辛未采纳,获得10
15秒前
Maestro_S的应助被辛未采纳,获得10
15秒前
maguodrgon发布了新的文献求助50
15秒前
科研通AI6.4的应助被dummer采纳,获得10
16秒前
小雨发布了新的文献求助200
16秒前
18秒前
十八与雨完成签到,获得积分10
18秒前
虚心的小周完成签到,获得积分10
19秒前
李林泽发布了新的文献求助10
19秒前
19秒前
20秒前
情怀的应助被VitoLi采纳,获得10
20秒前
Elisa完成签到 ,获得积分10
20秒前
20秒前
一盒火柴发布了新的文献求助10
21秒前
21秒前
大个的应助被Tuniverse_采纳,获得10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170866
求助须知:如何正确求助?哪些是违规求助? 9563691
关于积分的说明 21771699
捐赠科研通 7762353
什么是DOI,文献DOI怎么找? 3430767
关于科研通互助平台的介绍 2554622
邀请新用户注册赠送积分活动 2475597